Journal
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
Volume 17, Issue 5, Pages 253-255Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41575-020-0294-8
Keywords
-
Categories
Ask authors/readers for more resources
The coronavirus disease (COVID-19) worldwide outbreak has led to a dramatic challenge for all healthcare systems, including inflammatory bowel disease (IBD) centres. Here, we describe the fast changes and clinical issues that IBD specialists could face during this SARS-CoV-2 infection pandemic, highlighting the potential rearrangements of care and resetting of clinical priorities.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available